Occupational Therapy Can Play a Central Role in the Treatment of hATTR
Studies indicate that patients with hereditary transthyretin amyloidosis are aware that occupational therapy can improve their lives.
hATTR Insights
Strategies for Diagnosing and Treating Hereditary Transthyretin Amyloidosis
The accurate diagnosis and multidisciplinary treatment of hereditary transthyretin amyloidosis are central to improving patients’ quality of life.
Treating Cardiac ATTR: Current Strategies and Challenges
For many years, the treatment of cardiac hereditary transthyretin amyloidosis (hATTR) relied on liver transplantation to remove the source of aberrant transthyretin (TTR). However, several studies have shown that liver transplantation provided an incomplete cure. Hence, combined liver/heart transplantation has emerged as an alternative. In addition to obvious transplant-associated limitations, such as the dependence on…
The Challenging Task of Assessing Quality of Life in hATTR
hATTR has a severe impact on patients’ health and quality of life (QoL), but the tools used to assess QoL in hATTR are not specific to the disease.
Early Identification of hATTR-Associated Symptoms: Is It Possible?
The diversity in hATTR-associated symptoms, and their similarity to symptoms of other diseases, can make diagnosis difficult.
How hATTR Amyloidosis Can Impact the Quality of Life of Patients
Study findings indicate that physical pain/limitation and mental burden contribute to a poorer quality of life in patients with hATTR amyloidosis.
Patients With hATTR Could Face a Range of Ocular Manifestations
Patients with hATTR may develop ocular manifestations secondary to circulating TTR or due to the local production of mutant TTR.
The Range of Strategies Showing Promise for Improving the Treatment of hATTR
Specific drug formulations and additional compounds and strategies are being investigated to improve the treatment of hATTR.
A Rare Variant Responsible for Cardiac Manifestations in hATTR
The p.Ser43Asn variant is extremely rare and can be responsible for cardiac manifestations in patients with hATTR.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in hATTR Insights
Loading... 
Loading...